The NeurologyLive® multiple sclerosis (MS) clinical focus page offers information, podcasts, videos, and news about the latest study and clinical trial findings, FDA actions, clinical guideline updates, and expert interviews related to the care and management of patients with MS, including relapsing MS and progressive MS, as well as related disorders such as neuromyelitis optica spectrum disorder.
Check out some of NeurologyLive®'s featured content in the carousel below.
State of Care for Autoimmune Encephalitis and the ExTINGUISH Trial of InebilizumabFebruary 22nd 2023
Gregory Day, MD, MSc, MSCI, FAAN, a neurologist at Mayo Clinic in Jacksonville Florida, talked about the current state of treating autoimmune encephalitis and the significance of the ExTINGUISH trial.
Understanding NMOSD in Relation to Multiple Sclerosis: Michael Levy, MD, PhDFebruary 22nd 2023
The associate professor at Harvard Medical School spoke with NeurologyLive® about the differences between patients with multiple sclerosis and those with NMOSD. [WATCH TIME: 3 minutes]
Inside Look at Themes, Sessions at ACTRIMS 2023 Forum: Daniel Ontaneda, MDFebruary 22nd 2023
The program committee vice-chair of ACTRIMS provided perspective on the upcoming forum, including the notable sessions, themes, and presentations the clinical community should be aware of. [WATCH TIME: 7 minutes]
Real-World Findings Show Numerous Benefits for Older Patients With MS Switching to TeriflunomideFebruary 21st 2023
Patients who switched from a previous disease-modifying therapy to teriflunomide saw a decrease in annualized relapse rate and stability with Expanded Disability Status Scale scores regardless of subgroups.
ACTRIMS 2023: What to Expect From the Annual ForumFebruary 20th 2023
Daniel Ontaneda, MD, program committee vice-chair of ACTRIMS, provided insight on the notable sessions and themes clinicians should pay attention to at this year’s forum, which takes place February 23-25, in San Diego, California.
CNM-Au8 Shows Positive Findings on MS-Related Biomarkers of Whole Brain, White MatterFebruary 14th 2023
On diffusion tremor imaging, CMN-Au8 outperformed placebo on domains of fractional anisotropy, radial diffusivity, and mean diffusivity, across all 9 prespecified brain regions and brain white matter.
Phase 3 Antelope Trial Highlights Similarities in Efficacy, Safety With Biosimilar NatalizumabFebruary 8th 2023
The biosimilar form of natalizumab demonstrated similarities to the FDA-approved form in the primary efficacy end point of cumulative number of new active lesions over 24 weeks.
Sanofi Discontinues Phase 3 Study of Tolebrutinib in Myasthenia GravisFebruary 7th 2023
The trial was originally placed on hold because of reported cases of drug-induced liver injury in patients who received the study drug, potentially caused by a preexisting factors related to hepatic dysfunction.
National Women Physicians Day: 10 Moments That Matter in MedicineFebruary 3rd 2023
The list of women's contributions to the field of medicine is a long one, encompassing the hard work of hundreds of individuals. To highlight some of these pioneers, NeurologyLive® has compiled a timeline of 10 of the moments that matter in the history of women in medicine.
State of Mental Health Care for Patients With MS: Dawn Edhe, PhDFebruary 1st 2023
The psychologist and professor in the department of rehabilitation medicine at the University of Washington shared her perspective on the state of mental health care in multiple sclerosis. [WATCH TIME: 4 minutes]
Whole Brain Volume Loss, Higher Thalamic and Hippocampal Atrophy Rate Identified in MOGADJanuary 31st 2023
A cross-sectional and longitudinal comparative analysis suggests a subclinical neurodegenerative process may occur in MOG antibody disease based on a distinct pattern of brain atrophy.
NeurologyLive® Brain Games: January 29, 2023January 29th 2023
Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is neuromyelitis optica spectrum disorder, or NMOSD.
Understanding the National MS Society's New Mental Health Guidance: Dawn Edhe, PhDJanuary 27th 2023
The psychologist and professor in the department of rehabilitation medicine at the University of Washington talked about the benefits of a new initiative from the National MS Society focusing on mental health. [WATCH TIME: 4 minutes]